Breast Health
All Breast Health articles
566 articles · showing 91–120
Study: Vitamin D May Influence Breast Cancer Outcome (dateline June 7, 2008)
Women diagnosed with breast cancer who have vitamin D deficiencies are more likely to have poorer outcomes compared to those with normal vitamin D levels, according to the results of a new study.
Life Expectancy Decreasing in the United States for Some Groups (dateline May 27, 2008)
A new study finds that overall life expectancy in the United States increased over the past several decades but not for all citizens.
Study: Shorter Radiation Regimen May be Effective for Early-Stage Breast Cancer (dateline May 25, 2008)
A shorter duration of radiation therapy may be as beneficial for treating breast cancer as traditional five to six week regimens, according to a recent study.
Researchers Explore Possibility of Breast Cancer Blood Test (dateline April 28, 2008)
A protein called mammastatin is being studied to determine whether it can help predict which women are likely to develop breast cancer. First identified in 1986, mammastatin is thought to be produced naturally by breast cells.
Taking Femara After Tamoxifen May Reduce Risk of Breast Cancer Recurrence (dateline March 18, 2008)
Tamoxifen is the most commonly used drug to treat breast cancer, but new research suggests that another drug, Femara, may help decrease the risk of a breast cancer recurrence in women who have already taken tamoxifen.
FDA Approves Avastin for Breast Cancer Treatment (dateline February 26, 2008)
Editor's note: In July 2010, an FDA advisory panel recommended that Avastin no longer be administered to breast cancer patients along with chemotherapy.
Researchers Find that More Than Three Years of Hormone Replacement Therapy May Increase Risk of Lobular Breast Cancer (dateline January 23, 2008)
Results from the largest study of its kind show that using hormone replacement therapy (HRT) for over three years could increase the risk of a certain type of breast cancer called lobular carcinoma. Earlier research had shown that more than five years of HRT use could increase breast cancer risk.
Report: Americans without Health Insurance Less Likely to Survive Cancer (dateline January 21, 2008)
A new report by American Cancer Society researchers finds that Americans without adequate health insurance are less likely to receive appropriate health care services.
Researchers Continue to Investigate Link between Diet and Cancer (dateline January 6, 2008)
Does diet or exercise influence a person's risk of dying from cancer? It is a question that researchers have been struggling with for years. The scientific data are mixed.
Research Moving Toward Personalizing Breast Cancer Treatment (dateline January 4, 2008)
Recent research suggests that analyzing individual characteristics of breast cancer tumors can provide a more effective treatment while avoiding unnecessary therapies with often serious side effects.
FDA Approves Raloxifene for Women with Invasive Breast Cancer (dateline December 7, 2007)
The risk of developing breast cancer may have been underestimated in African-American women, according to the results of a recent study.
FDA Approves Raloxifene for Women with Invasive Breast Cancer (dateline November 12, 2007)
The U.S. Food and Drug Administration (FDA) recently approved the drug raloxifene (brand name, Evista) to reduce the risk of invasive breast cancer in post-menopausal women with osteoporosis and in post-menopausal women at high risk for invasive breast cancer.
Simple Blood Test May Indicate Whether Breast Cancer Treatment is Working
A new blood test shows promise in helping physicians better manage the treatment of women with advanced breast cancer.
Survey Illustrates What Women Don't Know about Breast Cancer (dateline October 13, 2007)
To coincide with National Breast Cancer Awareness Month in the United States, the National Breast Cancer Coalition (NBCC) recently released the results of a survey to determine how informed women are about breast cancer.
October 19 is National Mammography Day (dateline October 11, 2007)
Friday, October 19, 2007, has been designated National Mammography Day in the United States. Women are encouraged to use this day as a reminder to make an appointment to get a mammogram.
Researchers Investigating Breast Cancer Vaccine (dateline August 26, 2007)
Researchers are studying whether a vaccine similar to one being developed for prostate cancer would help treat breast cancer. The vaccine, called Neuvenge, is designed to target certain types of breast cancer cells in women whose cancers have spread to other organs despite treatment.
Researchers Seeking More Minority Women for 'Sister Study' on Breast Cancer Risk Factors (dateline August 25, 2007)
Researchers of a large breast cancer study of sisters are encouraging more minority women to enroll to ensure a diverse study sample and far-reaching results. The National Institute of Environmental Health Sciences (NIEHS) plans to enroll 50,000 women in its Sister Study by the end of 2007.
New Breast Chek® Kit Helps Women Perform Self-Exams (dateline July 29, 2007)
Courtesy of Plexus Worldwide, Inc. Women have a new option to help them perform their monthly breast self-exams. The Breast Check Self-Examination Kit, recently approved by the U.S.
Booklet Provides Assistance for Older Patients Living with Cancer (dateline June 25, 2007)
The American Society of Clinical Oncology has published a booklet entitled, "Cancer in Older Adults," which provides information on more than 120 types of cancer and cancer-related syndromes, clinical trials information, coping resources, information on managing side effects, medical illustrations,
Four Studies Reveal Advances in Women's Cancer Research
The results of four new studies presented at the annual meeting of the American Society of Clinical Oncology (ASCO) reveal advances in the field of women's cancer research.
National Breast Cancer Coalition Fund Accepting Applications for Best Practices Awards in Breast Cancer Advocacy (dateline June 22, 2007)
The National Breast Cancer Coalition Fund will award seven consumer-led grassroots advocacy organizations $25,000 or $50,000, in recognition of their strategic, high-impact programs that are addressing critical issues in the systems of research, access to quality care and public policy.
Study: Breast Cancer May be More Deadly in Men (dateline June 3, 2007)
While only about 1% of men are diagnosed with breast cancer, a recent study finds that men may be at higher risk than women of dying from the disease.
Study Finds That Fewer Women Are Getting Mammograms (dateline June 1, 2007)
Mammography is the gold standard in breast cancer detection, but a new study shows that fewer women have been getting mammograms in recent years. According to the study, after years of increased mammography rates, between 2000 and 2005, mammography rates leveled off and then eventually fell by 4%.
Number of Breast Cancer Cases Continue to Decline (dateline May 16, 2007)
New research reveals that breast cancer cases declined by over 8% from 2001 through 2004. The results of this research complement a U.S. government study published in December 2006 that found that 7% fewer women were diagnosed with breast cancer between 2002 and 2003.
FDA Approves New Breast Cancer Drug, Tykerb (dateline May 14, 2007)
The U.S. Food and Drugs Administration (FDA) has approved the use of a new drug, Tykerb (generic name, lapatinib) for advanced breast cancer patients. Tykerb can be used along with another drug, Xeloda (generic name, capectabine).
Study: Switching Breast Cancer Drugs during Treatment Could Increase Survival (dateline April 30, 2007)
Switching from the drug tamoxifen to Aromasin (generic name, exemestane) two to three years after treatment could decrease a woman's risk of dying from breast cancer, according to the results of a recent study. Many women are treated with the drug tamoxifen for breast cancer.
Lifetime Television Leads Effort to End 'Drive-Through Mastectomies' as U.S. Breast Cancer Patient Protection Act is Reintroduced (dateline April 28, 2007)
For a decade, Lifetime Television has been gathering signatures in an effort to help end "drive through mastectomies." To try to reduce the cost of inpatient healthcare costs, many insurance companies have been requiring that breast cancer patients be released from the hospital soon after their brea
American Cancer Society Still Recommends Women Begin Annual Mammograms at Age 40 (dateline April 20, 2007)
While mammography guidelines have been debated by health experts in recent years, the American Cancer Society announced that it is keeping its recommendation that women begin receiving annual mammograms at age 40.
MRI Screening Recommended for Some Women at Very High Risk of Breast Cancer (dateline April 2, 2007)
The American Cancer Society recommends that women at very high risk of developing breast cancer have annual breast MRI exams in addition to annual mammograms to increase the likelihood that breast cancer will be detected early, when the chances of survival are greatest.
Study: Many Breast Cancer Patients Quit Treatment with Tamoxifen (dateline March 31, 2007)
Research has shown that five years is the optimal amount of time to take tamoxifen to help treat breast cancer and prevent its recurrence, but a new study from Ireland finds that many women stop taking tamoxifen early.